These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7031840)

  • 1. Antithrombin III concentrate: its catabolism in health and in antithrombin III deficiency.
    Tengborn L; Frohm B; Nilsson LE; Nilsson IM
    Scand J Clin Lab Invest; 1981 Sep; 41(5):469-77. PubMed ID: 7031840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties and catabolism of heat treated antithrombin III concentrate.
    Tengborn L; Frohm B; Nilsson LE; Johansson L; Andersson LO
    Thromb Res; 1987 Dec; 48(6):701-11. PubMed ID: 3433260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Crossed immunoelectrophoresis of congenital antithrombin III (AT) III deficiency, with special reference to the effects of AT III concentrate].
    Matsuo T; Ohoki Y; Kobayashi H; Yamada T
    Rinsho Ketsueki; 1983 Aug; 24(8):1026-31. PubMed ID: 6645071
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of planned pregnancy in a patient with congenital antithrombin III deficiency.
    Samson D; Stirling Y; Woolf L; Howarth D; Seghatchian MJ; de Chazal R
    Br J Haematol; 1984 Feb; 56(2):243-9. PubMed ID: 6691921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital Antithrombin Deficiency in a Pregnant Woman with Right Atrium Thrombosis.
    Sabzi F; Khosravi D; Faraji R
    Ethiop J Health Sci; 2015 Oct; 25(4):385-9. PubMed ID: 26949306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of elimination of antithrombin III concentrate in heparinized patients.
    Marciniak E; Gockerman JP
    Br J Haematol; 1981 Aug; 48(4):617-25. PubMed ID: 7272219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombin III transfusion in patients with hepatic cirrhosis.
    Schipper HG; ten Cate JW
    Br J Haematol; 1982 Sep; 52(1):25-33. PubMed ID: 7115627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of congenital antithrombin III deficiency with concentrates.
    Mannucci PM; Boyer C; Wolf M; Tripodi A; Larrieu MJ
    Br J Haematol; 1982 Mar; 50(3):531-5. PubMed ID: 7066204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catabolism and distribution of functionally heterogeneous human antithrombin III.
    Marciniak E; Romond EH
    J Lab Clin Med; 1987 Jan; 109(1):89-96. PubMed ID: 3794520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxymetholone therapy in patients with familial antithrombin III deficiency.
    Shibuya A; Ninomiya H; Nakazawa M; Nagasawa T; Yoda Y; Abe T
    Thromb Haemost; 1988 Dec; 60(3):495-7. PubMed ID: 3238652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purified radiolabeled antithrombin III metabolism in three families with hereditary AT III deficiency: application of a three-compartment model.
    Knot EA; de Jong E; ten Cate JW; Iburg AH; Henny CP; Bruin T; Stibbe J
    Blood; 1986 Jan; 67(1):93-8. PubMed ID: 3940555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary antithrombin III deficiency: case report and review of recent therapeutic advances.
    Miller N; Hultin MB; Gounder M; Zarrabi MH
    Am J Hematol; 1986 Feb; 21(2):215-21. PubMed ID: 3942133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Management with antithrombin III concentrate in a pregnant woman with hereditary antithrombin III deficiency].
    Higuchi M; Konya H; Tanaka H; Masuda H; Nishida Y; Koyama T; Suehiro A; Kakishita E; Ishita K
    Rinsho Ketsueki; 1990 Sep; 31(9):1544-7. PubMed ID: 2246830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of venous thrombosis in antithrombin III deficient patients with concentrates of antithrombin III.
    Winter JH; Fenech A; Mackie M; Bennett B; Douglas AS
    Clin Lab Haematol; 1982; 4(2):101-8. PubMed ID: 7116792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo behavior of radioiodinated rabbit antithrombin III. Demonstration of a noncirculating vascular compartment.
    Carlson TH; Atencio AC; Simon TL
    J Clin Invest; 1984 Jul; 74(1):191-9. PubMed ID: 6376543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditions for radioiodination of antithrombin III retaining its biological properties.
    Caix J; Perrot Minnot A; Beziade A; Vuillemin L; Belloc F; Baquey C; Ducassou D
    Int J Rad Appl Instrum A; 1987; 38(12):1003-6. PubMed ID: 2828272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital and acquired defects of antithrombin III.
    Sas G
    Ric Clin Lab; 1984; 14(3):491-7. PubMed ID: 6395295
    [No Abstract]   [Full Text] [Related]  

  • 18. The plasma turnover of transfused antithrombin concentrate in patients with acquired antithrombin deficiency.
    Harper PL; Park GR; Carrell RW
    Transfus Med; 1996 Mar; 6(1):45-50. PubMed ID: 8696447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of the "classical" antithrombin III deficiency.
    Sas G; Petö I; Bánhegyi D; Blaskó G; Domján G
    Thromb Haemost; 1980 Jun; 43(2):133-6. PubMed ID: 7455972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with antithrombin III concentrate in treatment of congenital and acquired deficiency of antithrombin. The Antithrombin III Study Group.
    Schwartz RS; Bauer KA; Rosenberg RD; Kavanaugh EJ; Davies DC; Bogdanoff DA
    Am J Med; 1989 Sep; 87(3B):53S-60S. PubMed ID: 2679072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.